Company
Ally Bridge Group
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| AdvanCell | Series D | 2026-07-15 | Lead |
| Calyxo, Inc. | Series F | 2026-04-14 | Lead |
| Imperative Care, Inc. | Convertible Note | 2026-03-18 | |
| Solve Therapeutics | Funding | 2025-11-17 | |
| Galvanize Therapeutics | Series C | 2025-09-03 | |
| SetPoint Medical | Financing | 2025-08-11 | Lead |
| Mission Bio | Equity Financing | 2025-08-06 | Lead |
| Epicrispr Biotechnologies | Series B | 2025-03-26 | Lead |
| Cardiac Dimensions | Series E | 2025-03-21 | Lead |
| Aerin Medical | Funding | 2025-01-13 | |
| Kestra Medical Technolog ies | Funding | 2024-07-24 | Lead |
| Transcarent | series d | 2024-05-02 | |
| Endeavor BioMedicines, Inc | Series C Funding | 2024-04-24 | |
| ProfoundBio | Series B | 2024-02-13 | Lead |
| Elligo Health Research | Investment | 2023-10-02 | |
| LightForce Orthodontics | Series D Funding | 2023-08-02 | Lead |
| Relievant Medsystems | Series G Funding | 2023-04-21 | Lead |